Skip to main navigation Skip to search Skip to main content

Tirofiban and Rivaroxaban use in the management of right coronary artery thrombus as a primary manifestation of essential thrombocythemia

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Tirofiban and Rivaroxaban use in the management of right coronary artery thrombus as a primary manifestation of essential thrombocythemia'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science